Diagnostic performance of Kaiser score, ADC, and their combination for BI-RADS 4 breast lesions: subgroup and misclassification analysis
Open Access
- 23 July 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1802360
Abstract
Background: The Kaiser score and apparent diffusion coefficient (ADC) have been proposed as diagnostic adjuncts to reduce unnecessary biopsies in Breast Imaging Reporting and Data System (BI-RADS) 4 breast lesions. However, which specific histopathologic entities are prone to misclassification by each diagnostic model remains poorly characterized, limiting clinical guidance for borderline cases. Objective: To compare the diagnostic performance of the Kaiser score, ADC, and their combination (Kaiser+) stratified by lesion morphology, and to identify histopathologic subtypes most susceptible to misclassification. Methods: This retrospective study included 222 patients with BI-RADS 4 breast lesions confirmed by histopathology. Two radiologists independently evaluated lesions using the Kaiser score and ADC values (threshold: 1.4 × 10 -3 mm²/s). Diagnostic performance was assessed using receiver operating characteristic (ROC) analysis, and misclassification patterns were analyzed by pathologic subtype using McNemar’s test with Bonferroni correction. Results: The Kaiser score achieved the highest area under the curve (AUC) of 0.901 (95% CI: 0.856–0.941), followed by Kaiser+ (AUC 0.890; 95% CI: 0.845–0.930) and ADC alone (AUC 0.733; 95% CI: 0.666–0.800; p < 0.001 vs. Kaiser). Kaiser demonstrated superior performance in mass lesions (AUC 0.926; 95% CI: 0.878–0.965) compared with non-mass enhancement (NME) (AUC 0.801; 95% CI: 0.681–0.905). Pathology-stratified analysis revealed distinct misclassification patterns: fibroadenoma, breast hyperplasia, and intraductal papilloma accounted for most FP cases, with ADC showing significantly higher FP rates (66.1%; 95% CI: 57.3%–73.9%) than Kaiser (19.8%; 95% CI: 13.7%–27.8%) or Kaiser+ (17.4%; 95% CI: 11.6%–25.1%; p in situ (DCIS) and mucinous carcinoma were the majority of frequently misclassified as FN across all models. Conclusion: The Kaiser score outperformed ADC alone in BI-RADS 4 lesions. Pathology-stratified analysis identified subtype-specific diagnostic pitfalls: benign cellular and proliferative lesions drive FP cases (especially with ADC), while low-conspicuity malignancies (DCIS, mucinous carcinoma) drive FN cases. Awareness of these patterns may guide individualized biopsy decisions in clinical practice.Keywords
This publication has 34 references indexed in Scilit:
- Kaiser score diagnosis of breast MRI lesions: Factors associated with false-negative and false-positive resultsEuropean Journal of Radiology, 2024
- Added value of clinical decision rules for the management of enhancing breast MRI lesions: A systematic comparison of the Kaiser score and the Göttingen scoreEuropean Journal of Radiology, 2023
- The added value of apparent diffusion coefficient and microcalcifications to the Kaiser score in the evaluation of BI-RADS 4 lesionsEuropean Journal of Radiology, 2023
- Can DWI provide additional value to Kaiser score in evaluation of breast lesionsEuropean Radiology, 2022
- Diagnostic performance of the Kaiser score for characterizing lesions on breast MRI with comparison to a multiparametric classification systemEuropean Journal of Radiology, 2021
- Test–retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trialJournal of Magnetic Resonance Imaging, 2018
- How to use the Kaiser score as a clinical decision rule for diagnosis in multiparametric breast MRI: a pictorial essayInsights into Imaging, 2018
- Diffusion-weighted imaging reflects variable cellularity and stromal density present in breast fibroadenomasClinical Imaging, 2016
- Combined reading of Contrast Enhanced and Diffusion Weighted Magnetic Resonance Imaging by using a simple sum scoreEuropean Radiology, 2015
- A simple and robust classification tree for differentiation between benign and malignant lesions in MR-mammographyEuropean Radiology, 2013